Second-line gemcitabine-based chemotherapy regimens improve overall 3-year survival rate in patients with malignant pleural mesothelioma: a multicenter retrospective study

Mutlu, Hasan; Gunduz, Seyda; Karaca, Halit; Buyukcelik, Abdullah; Cihan, Yasemin Benderli; Erden, Abdulsamet; Akca, Zeki; Coskun, Hasan Senol

doi:10.1007/s12032-014-0074-9

Second-line gemcitabine-based chemotherapy regimens improve overall 3-year survival rate in patients with malignant pleural mesothelioma: a multicenter retrospective study

Date

2014

Authors

Cihan, Yasemin Benderli

Erden, Abdulsamet

Akca, Zeki

Coskun, Hasan Senol

dc.identifier.doi

10.1007/s12032-014-0074-9

dc.identifier.other

WOS:000340095700055

Publisher

HUMANA PRESS INC

DOI

10.1007/s12032-014-0074-9

Keywords

Mesothelioma , Gemcitabine , Second\\-line , Survival

URI

https://openaccess.acibadem.edu.tr/handle/11443/9169

Collections

WOS

Full item page

Second-line gemcitabine-based chemotherapy regimens improve overall 3-year survival rate in patients with malignant pleural mesothelioma: a multicenter retrospective study

Date

Authors

Journal Title

Journal ISSN

Volume Title

dc.identifier.issn

dc.identifier.doi

dc.identifier.other

dc.description.volume

dc.description.issue

Publisher

DOI

Abstract

Description

Keywords

Citation

URI

Collections

Endorsement

Review

Supplemented By

Referenced By